Artemisiniiniyhdistelmähoito
Artemisiniiniyhdistelmähoito, often abbreviated as ACT (Artemisinin-based Combination Therapy), is a standard treatment for uncomplicated malaria. It involves the use of a drug containing an artemisinin derivative in combination with one or more other antimalarial drugs. The artemisinin component acts quickly to reduce the number of parasites in the blood, while the partner drug(s) help to eliminate any remaining parasites. This combination approach is highly effective because it significantly reduces the risk of drug resistance developing.
The World Health Organization (WHO) recommends ACTs as the first-line treatment for Plasmodium falciparum malaria, the
ACTs have played a crucial role in reducing malaria morbidity and mortality globally. Their effectiveness stems